92°F
Sponsored by

Smart Woman: One Time Antibiotic?

Scientists say a new antibiotic can treat serious skin infections, including resistant ones like MRSA (pronounced mersa), with just one dose. Oritavancin is unique in that because of its ability to stay in the body for long periods of time.
Scientists say a new antibiotic can treat serious skin infections, including resistant ones like MRSA (pronounced mersa), with just one dose. Oritavancin is unique in that because of its ability to stay in the body for long periods of time. Currently, the standard treatment for resistant skin infections requires two daily doses of antibiotics for up to ten days. Now a study published in the New England Journal of Medicine on one thousand patients found one intravenous dose of Oritavancin was just as effective.

Treating serious skin infections can mean days in the hospital for some patients, but researchers say this new drug could prevent or shorten hospital stays. Dr. Ralph Corey, Professor of Medicine, Infectious Diseases at Duke University School of Medicine says, "You can be discharged from the ER to go back home and gradually cure the infection over the next 7-10 days." Researchers say another benefit to only needing one treatment: patients are less likely to miss a dose.

The Medicines Company funded the study and have submitted the drug to the FDA. Researchers say there were minor side effects, including nausea and headaches.
Page: [[$index + 1]]
comments powered by Disqus
Looking for a Job?